The photo irritation test and the photosensitivity will be measured using UVA irradiation and evaluated according International Contact Dermatitis Research Group (ICDRG) scale. The sensibility will be evaluated according to the skin type. [ Time Frame: 5 weeks ] [ Designated as safety issue: Yes ]

Enrollment:

25

Study Start Date:

December 2007

Primary Completion Date:

January 2008 (Final data collection date for primary outcome measure)

Eligibility

Ages Eligible for Study:

18 Years to 60 Years

Genders Eligible for Study:

Female

Accepts Healthy Volunteers:

Yes

Criteria

Inclusion Criteria:

Phototype Skin II and III

Integral skin test in the region

Exclusion Criteria:

Lactation or gestation;

Use of Antiinflammatory and/or immunosuppression drugs 15 days before the selection

Diseases which can cause immunity decrease, such as HIV, diabetes

Use of drug photosensitizer

History of sensitivity or irritation for topic products

Active cutaneous disease which can change the study results

History or photodermatosis active

Family or personal antecedent of cutaneous photoinduced neoplasias

Presence of a precursor lesion of cutaneous neoplasia, such as nevus melanocyte and keratoses actinium

Intense solar exposure in the study area

Use of new drugs or cosmetics during the study

The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study.
To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below.
For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00668226